The company shared interim results from an ongoing Phase II trial examining its recombinant antibody fusion protein.
Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Secretome ...
Zacks.com on MSN6h
GLP-1 Drugs Cut Risk of Alzheimer's, NVO & LLY Shares RiseThe stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...
Inc. (Nasdaq: TENX) (“” or the “Company”), a Phase 3, development-stage pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary ...
Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing novel complex biologic therapeutics, today announced positive interim data ...
Hosted on MSN22h
Microplastics in Water; New NCD for CardioMEMS; Valve Surgery Amid Los Angeles FiresMultiple societies endorsed the new appropriate-use criteria for implantable cardioverter defibrillators, cardiac ...
Cytokinetics, Inc. (CYTK), a biopharmaceutical company focused on muscle biology, on Monday announced the launch of the AMBER-HFpEF ...
Stifel initiated coverage of Cytokinetics (CYTK) with a Buy rating and $80 price target Cytokinetics “is an out-of-favor stock” following the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback